Skip to main content
DHTI logo

DHTI · Dalrada Technology Group, Inc.

Track DHTI — free
$0.02 0.00 (-21.05%) At close · Sep 1
Market Cap
$2.28M
Shares
120.16M

DHTI metrics

53 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.02
Market cap
$2.28M

Price action

19 metrics
Price change (1W)
+25.0%
Price change (30D)
+50.0%
Price change (3M)
-44.4%
Price change (6M)
-62.5%
Price change (YTD)
-54.5%
Price change (1Y)
-70.6%
Trailing year
Price change (5Y)
-94.2%
52-week high
$0.08
52-week low
$0.00
Change from 52-week high
-80.5%
Change from 52-week low
+316.7%
Annualized volatility
537.2%
Beta
2.4
RSI (14D)
51.4
Price vs SMA 50
-7.2%
Price vs SMA 200
-53.3%
Avg volume (3M)
40,533
Relative volume
0.5
Average dollar volume
$452

Company

3 metrics
Sector
Healthcare
Industry
Pharmaceutical Retailers
Shares outstanding
120.16M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
0.1×
reciprocal yield 723.1%
P / book
FCF yield
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-952.7%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings

Profitability

9 metrics
Gross margin
26.4%
Operating margin
-108.6%
Trailing 12 months
Net margin
-131.8%
Gross profit (TTM)
$4.36M
Operating profit (TTM)
−$17.93M
Net income (TTM)
−$21.75M
Trailing 12 months
Diluted EPS (TTM)
$-0.18
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$-0.02

Growth

11 metrics
Revenue growth YoY
-43.9%
Year over year
Net income growth YoY
Revenue (TTM)
$16.51M
Trailing 12 months
EPS growth YoY
Shares change YoY
+16.7%
Year over year · more shares
Revenue CAGR (3Y)
+1.8%
Revenue CAGR (5Y)
+76.7%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
Return on assets
-122.8%
Debt / equity
Current ratio
0.3
EBITDA (TTM)
−$16.93M
Free cash flow (TTM)
Quick ratio
0.2
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
$82,625
Latest balance sheet
Cash & equivalents
$82,625
Total assets
$17.72M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$17.89M
Capital expenditures (TTM)
R&D (TTM)
$0
SG&A (TTM)
$19.56M
Stock compensation (TTM)
$699,208
R&D / revenue
0.0%
Stock compensation / revenue
4.2%

Ownership (13F)

3 metrics
13F filers
13F filer change QoQ
Institutional ownership

Short interest

3 metrics
Short interest
Latest settlement
Days to cover
Short-squeeze score

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 725394 Visit website